Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer

Clinical trial NCT04059484 · TERMINATED

Trial details

NCT number: NCT04059484
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Metastatic

Start date: 2019-10-22
Primary completion: 2022-02-15
Enrollment: 367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.